Michael B. Jameson
0000-0001-7068-4311
University of Auckland
1 paper found
Refreshing results…
Long-Term Follow-Up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients With Advanced Melanoma: KEYNOTE-029 Part 1B
Missing publications? Search for publications with a matching author name.